Skip to main content
Free shipping on all orders
888-559-3802
Go back
VitabaseIngredients

Garbanzo bean

Health Conditions17
Table of contents

Other Names

Bengal grambutcatjang arabcecececiceci beanchanachanakachannachholachholechicherchick peachickpeacholachunnaCicer album Hort.Cicer arietinum L.Cicer asiaticumCicer edessanum Bornm.Cicer grossum Salisb.Cicer nigrum Hort.Cicer orientaleCicer physodes Rchb.Cicer rotundum Jord.Cicer rotundum Jord. ex Alef.Cicer sativum Schkuhr.cieciorkadavulgadhaleEgyptian peaervançogarbanzogarvancegoyun nokhudgramgram peagrão de bicogravançohamazhamsaharbarahiyoko mamehommeshummusIndian gramIndian peakadalaikadalekadale kaalukahvihernekala-pekatjang arabkicharkichererbsekonda-kadalalablabimdengumukhudomyinsa-penakhutnavadna čičerikanhanaNochotta oleracea S.G.Gmel.nohutOnonis crotalarioides M.pitipoankaranypois chichesanaga pappusanagalushimbrasingaung-peVicia arietina (L.) E.H.L.Krauseying zui dou

Synopsis

Garbanzo Bean (Cicer arietinum L.): A Comprehensive Reference

1. Identity: Botanical Names, Taxonomy, and Common Forms

The chickpea or chick pea (Cicer arietinum) is an annual legume of the family Fabaceae, subfamily Faboideae, cultivated for its edible seeds. Its different types are variously known as gram, Bengal gram, chana, garbanzo, garbanzo bean, or Egyptian pea. The name chickpea comes from the Latin word cicer, referring to the plant family of legumes, Fabaceae; it is also known by its popular Spanish-derived name, the garbanzo bean.

Carl Linnaeus described it in the first edition of Species Plantarum in 1753, marking the first use of binomial nomenclature for the plant. Linnaeus classified the plant in the genus Cicer, which was the Latin term for chickpeas, crediting Joseph Pitton de Tournefort's 1694 publication. The specific epithet arietinum is based on the shape of the seed resembling the head of a ram.

Cicer arietinum L. is an annual plant of the family Fabaceae, mainly grown in semiarid and temperate regions. The plant grows to 20–50 cm high and has small, feathery leaves on either side of the stem.

Varieties

Two main varieties of chickpeas are the larger round light-colored Kabuli-type, common in the United States, and the smaller dark irregularly shaped Desi-type often used in India and the Middle East. Out of 43 species in the Cicer genus, only C. arietinum has been cultivated. The cultivated species grown today, Cicer arietinum, is a probable descendant of the wild species, Cicer reticulatum.

Common Forms and Preparations

Chickpeas are widely available dried or canned; occasionally young, fresh green chickpeas in their pods may be found at farmers' markets. Seeds may be harvested when immature and eaten raw, roasted, or boiled, or when mature and dry processed into flour. Hummus is a dip or spread made using cooked and mashed chickpea seeds mixed with tahini, olive oil, lemon juice, garlic, and salt, and is a traditional dish in the Middle East, Turkey, and North Africa. Sprouted chickpea seeds are eaten as a vegetable or added to salads; young plants and green pods are eaten like spinach; chickpea seeds are ground to make flour, which is used to make soup, dhal, and bread. Roasted chickpea roots have been used as a coffee substitute.

Chickpea can be used to make gluten-free bread comprising 75% chickpea flour blended with 25% potato or cassava starch, for individuals with gluten-related disorders, enhancing nutritional quality including dietary fiber.

2. Traditional and Historical Use

Origins and Antiquity

According to archaeological records, Cicer arietinum was first domesticated in the Fertile Crescent about 10,000 years BP. Based on archaeological evidence, the distribution of compatible wild relatives, and pan-genome analysis, the upper reaches of Mesopotamia in southeastern Turkey is generally accepted as the origin of chickpea. The domesticated chickpea varieties further spread from the Fertile Crescent westward and eastward into Europe, Northern Africa, and Asia. Chickpeas appear in early recordings in Turkey about 3500 BCE and in France 6790 BCE.

Ancient Greece and Rome

The source material demonstrates that the medicinal properties of the chickpea and its therapeutic use were discussed by Greek physicians as early as in the fourth century BC. It seems that the plant was a readily accessible medicament and thus used in therapy also by those who could not afford costly medicines; the medical theory concerning its role in therapeutics evolved into a fully developed form only in the first century AD (thanks to Dioscorides) and was not modified by Galen.

A significant number of medicinal recipes which involved using the chickpea were formulated between the second century BC and the second century AD. Byzantine physicians avidly used these formulas in their practice. Medical writings may serve as proof that the chickpea remained a key element in the Mediterranean diet throughout the period from the fourth century BC to the seventh century AD.

Chickpea has been used in traditional medicines since Roman times. Through trade routes, chickpeas traveled to Greece, where Hippocrates praised them for urinary irritations. Romans later introduced garbanzo to Europe; medieval herbals in Spain recommended chickpea poultices for sores and inflammations.

Ayurvedic and South Asian Traditions

In ancient Vedic literature, chickpeas appear under the Sanskrit name "chana," referenced in the Sushruta Samhita (circa 600 BCE) as a gentle digestive aid; they were often ground into a cake (pinda) or cooked as a porridge (yusha) for convalescing patients. By the 16th century, Mughal court physicians in India used chana dhuli (dehulled chickpea) for balancing aggravated Pitta dosha, often in a cooling kheer preparation. In South Indian Siddha practice, sprouted chickpeas were heated with ghee and rock salt and applied externally to reduce joint pain.

Middle Eastern and Mediterranean Culinary-Medical Use

Garbanzo beans have been eaten in the Middle East for more than 10,000 years, and are a staple of Middle Eastern, African, and Indian cuisines. In ancient times, they were extremely popular in Greece, Rome, and Egypt; over the millennia, culinary traditions related to chickpeas deepened and developed mainly in the countries of the Mediterranean basin—North Africa, the Middle East, Italy, Spain, and southern France.

3. Key Constituents and Active Compounds

Macronutrient Composition

Chickpeas are an excellent source of carbohydrate, protein, fiber, B vitamins, and some minerals, making them a nutritious staple of many diets. Chickpea seed typically contains 50–58% carbohydrates, with starch being the primary component (41–50.8%). Chickpea seed additionally contains cellulose (4–13%), hemicellulose (3.5–8.8%), and pectin (1.5–3.8%). Chickpeas provide nearly 20 grams of protein in a ½-cup serving and 5 grams of dietary fiber; they are also a source of folate, iron, vitamin C, and phosphorus.

Protein and Amino Acids

Chickpea is a good source of protein and carbohydrate, fiber, and an important source of essential minerals and vitamins; the quality of protein is better among other pulses. Among the protein fractions, globulins represent the highest proportion in chickpea, followed by albumin. Chickpea lacks sulfur-containing essential amino acids methionine and cysteine. Generally, sulphur-rich amino acids (methionine and cystine) are limiting in pulses. In vitro protein digestibility values for chickpea genotypes range from 65.3 to 79.4%, comparing favorably with pigeon pea, mung bean, urd bean, and soybean.

Chickpea hydrolysate and peptides have various bioactivities, including angiotensin 1-converting enzyme (ACE) inhibition, hypocholesterolemic effects, antioxidant activity, anti-inflammatory, antimicrobial, and anticarcinogenic activity. Due to limited research and technology, the sequences of peptides are still not fully known, making it difficult to conduct mechanism studies; emphasis must be given to optimizing production of chickpea bioactive peptides and conducting human study trials.

Bioactive Phytochemicals

Chickpea contains a large number of bioactive compounds including phytic acid, tannin, saponin, trypsin inhibitor, anthocyanin, carotenoid, isoflavones, tocopherol, and phenolic acid. Raw or cooked chickpeas and hummus contain dietary bioactives such as phytic acid, sterols, tannins, carotenoids, and other polyphenols such as isoflavones, whose benefits may extend beyond the basic nutrition requirements of humans.

  • Isoflavones: The chickpea contains organic compounds such as polyphenol and isoflavones, which are associated with a reduced risk of diabetes mellitus, inflammation, metabolic syndrome, and hypertension.
  • Saponins: Chickpeas have a 0.44% saponin concentration; boiled chickpeas show the greatest reduction in saponin content, possibly due to saponins leaching into the water; cooking decreases saponin content by 43.96–51.65%.
  • Resistant starch and dietary fiber: Soluble viscous fibers such as galactomannans, with good gelling properties, decrease gastric emptying, increase gastric distention and satiety, decrease the digestive process, and lower glucose release.
  • GABA (Îł-aminobutyric acid): The chickpea bioactive compound GABA is produced directly by L-glutamate decarboxylation; it is known for its capacity to lower blood pressure, relieve alcohol-related chronic disorders, stop cancer cell proliferation, and control cholesterol level.
  • Tannins: Tannins impede enzyme functioning, lowering digestibility; chickpea seeds have a tannin concentration of approximately 8.23 mg/g.
  • Carotenoids and other polyphenols: Chickpea harbors bioactive compounds including sterols, phenols, carotenoids, tannins, and isoflavones, with antioxidant properties and potential anti-glycemic and anti-cancer properties.
  • Germination effects: Germination significantly enhances the concentrations of total flavonoids and phenolics in chickpeas; compared to ungerminated seeds, total flavonoid content in chickpea sprouts increased by 3.95-fold and 3.25-fold, respectively, while total phenolic content increased by 2.47-fold and 2.38-fold.

Carbohydrate Structure and Glycemic Index

Kabuli and desi chickpea varieties contain amylose and amylopectin, with both types containing more amylopectin than amylose; chickpea starch has a low glycemic index, making it suitable for diabetic individuals. Foods considered a good source of energy and carbohydrates for diabetic persons are beans and pulses having lower GI, which help in the regulation of insulin secretion and glycemic condition in type 2 diabetic persons.

4. Scientific Evidence by Area of Use

4.1 Glycemic Control and Blood Glucose Regulation

A 2025 systematic review and meta-analysis published in Nutrition Journal assessed the impact of acute chickpea consumption on postprandial glucose and insulin responses in controlled, crossover trials. Researchers screened PubMed, the Cochrane Central Register of Controlled Trials (CENTRAL), and Embase from inception through March 21, 2024 for acute, controlled, experimental trials comparing chickpea consumption with carbohydrate-matched controls that reported on postprandial glucose and insulin responses. A total of 28 eligible studies (40 comparisons) were identified; chickpea consumption significantly reduced postprandial glucose iAUC compared to carbohydrate-matched controls (MD: −47.89, 95% CI: −64.20, −31.58, p < 0.0001). No significant effects were observed on glucose Cmax or insulin iAUC. Further high-quality studies are needed to confirm these findings, as the current evidence is of low to very low certainty.

One study explored the beneficial properties of chickpea consumption on suppressing appetite, blood glucose excursions, and energy intake, comparing chickpeas and white bread against a water control, fed to healthy female subjects at equal energy density, volume, and available carbohydrate content. Results suggest a reduction of 29–36% in blood glucose concentration and 83–98% energy compensation after chickpea consumption in the two experiments, respectively, compared to white bread.

A controlled diet with chickpeas has been demonstrated to result in decreases in plasma glucose and insulin concentration (Nestel, 2004), as well as reductions in serum total cholesterol and LDL-cholesterol (Pittaway, 2007), potentially contributing to lower risk of type 2 diabetes and coronary heart disease.

4.2 Cardiovascular Health and Lipid Profiles

In a randomized crossover weight maintenance dietary intervention in 47 free-living adults, each dietary period (chickpea-supplemented versus wheat-supplemented) lasting at least 5 weeks, serum total cholesterol and LDL-cholesterol levels were significantly lower (both p < 0.01) by 3.9% and 4.6%, respectively, after the chickpea-supplemented diet compared to the wheat-supplemented diet.

The small but significant decrease in serum total cholesterol and LDL-cholesterol during the chickpea diet compared to the equivalent-fiber wheat diet was partly due to unintentional changes in macronutrient intake occurring because of chickpea ingestion; if dietary energy and macronutrients were not controlled, chickpea consumption might result in greater benefits. Dietary supplementation with chickpeas for at least 5 weeks results in small but significant reductions in serum total and LDL-cholesterol in adult women and men.

Total cholesterol and LDL-cholesterol were found to be reduced in a group of 45 free-living adults after the consumption of a 12-week chickpea-enriched diet (104 g or approximately 1 serving per day, cooked), by 7.7 mg/dL (p = 0.002) and 7.3 mg/dL (p = 0.01), respectively.

Evidence from controlled trials encourages the intake of dietary pulses (beans, chickpeas, lentils, and peas) as a method of improving dyslipidemia, but heart health guidelines have stopped short of ascribing specific benefits to this type of intervention or have graded the beneficial evidence as low.

A British Journal of Nutrition study aimed to determine the effects of a pulse-based diet in individuals 50 years or older for reducing CVD risk factors; 108 participants were randomized to receive pulse-based foods (two servings daily of beans, chickpeas, peas, or lentils, about 150 g/d dry weight) or their regular diet for 2 months, followed by a washout of 1 month and a cross-over to the other diet for 2 months.

4.3 Satiety, Weight Management, and Body Composition

Dietary intake of pulses is associated with beneficial effects on body weight management and cardiometabolic health, but some of these effects are now known to depend on the integrity of plant cells, which are usually disrupted by flour milling; novel cellular flours preserve the intrinsic dietary fiber structure of whole pulses and provide a way to enrich preprocessed foods with encapsulated macronutrients. A study aimed to determine the effects of replacing wheat flour with cellular chickpea flour on postprandial gut hormones, glucose, insulin, and satiety responses to white bread.

A double-blind randomized crossover study in healthy human participants (n = 20) consumed bread enriched with 0%, 30%, or 60% (wt/wt) cellular chickpea powder (CCP, 50 g total starch per serving). The novel use of intact chickpea cells to replace refined flours in white bread stimulates an anorexigenic gut hormone response and has potential to improve dietary strategies for prevention and treatment of cardiometabolic diseases.

Chickpeas play a significant role in obesity management due to their high fiber and protein content, low glycemic index, and bioactive compounds. Dietary fiber and protein promote satiety, reduce calorie intake, stabilize blood sugar levels, and support effective weight management by ensuring sustained energy release and fostering gut health as prebiotics that encourage the growth of beneficial microbiota essential for weight regulation.

4.4 Gut Health and the Microbiome

The incorporation of chickpea-based functional foods in daily diet may reduce the risk of digestive tract diseases like irritable bowel syndrome (IBS), colon cancer, and ulcerative colitis, as well as nourish beneficial gut microbiota. Future studies should focus more on clinical and subclinical trials to confirm the mechanisms by which chickpea constituents influence gut health.

Butyrate is a principal short-chain fatty acid produced from consumption of a chickpea diet (200 g/day) in healthy adults; butyrate has been widely reported to suppress cell proliferation and induce apoptosis, which may reduce the risk of colorectal cancers. Several other dietary bioactive compounds—lycopene, Biochanin A, and saponins—that have been shown to reduce the risk of certain types of cancers are also present in chickpeas and hummus. The evidence for anti-cancer effects in humans, however, remains preliminary and is primarily derived from in vitro and mechanistic studies.

Oligosaccharides such as raffinose and stachyose are one primary example of antinutritional factors which contribute to intestinal discomfort and bloating. Some people who feel bloated after eating beans may find that presoaked beans are better tolerated, as this reduces the amount of oligosaccharides responsible for uncomfortable side effects.

4.5 Cancer — Preliminary and Mechanistic Evidence

Phytic acid, lectins, sterols, saponins, dietary fibers, resistant starch, oligosaccharides, unsaturated fatty acids, amylase inhibitors, and certain bioactive compounds such as carotenoids and isoflavones have shown the capability of lowering clinical complications associated with various human diseases. Current evidence for direct anti-cancer effects in humans is limited and based largely on in vitro and animal studies; no definitive human clinical trials specifically demonstrating cancer prevention from chickpea consumption have been established.

4.6 Bone Health — Preliminary Evidence

Network pharmacology research has examined mechanisms underlying the therapeutic effects of isoflavones isolated from chickpea sprouts in treating osteoporosis. Chickpea allergy prevalence is lower than peanut/soy, and fermentation also improves bone health and overall nutritional status by increasing the bioavailability of minerals through reduction of antinutritional factors. Human clinical evidence specifically for chickpea and bone health is sparse; this remains an area requiring further dedicated clinical investigation.

5. Body Systems and Associated Health Areas

  • Metabolic and Endocrine System: Food-derived compounds in chickpeas such as flavonoids, phenols, proteins, and peptides have potential antidiabetic activity; proteins, amino acids, peptides, and protein hydrolysates play an important role in blood glucose regulation.
  • Cardiovascular System: The soluble fiber and protein in chickpeas can help lower LDL cholesterol levels. Soluble fiber can help lower LDL cholesterol levels by binding to bile acids and removing them from the body, thereby reducing the amount of cholesterol produced in the liver.
  • Digestive System: Chickpea components including dietary fiber, protein, and phenolic compounds modulate colonic microbiota and gut health.
  • Immune and Inflammatory System: Dietary fiber and protein content in chickpeas may prevent the occurrence of cancer, reduce inflammation, and improve digestion.
  • Hematological System: Chickpeas are a source of folate, iron, vitamin C, and phosphorus.
  • Musculoskeletal System: Chickpea isoflavones have been studied in the context of osteoporosis, primarily in preclinical and network pharmacology analyses; human data remain limited.

6. Dosage Forms and Reported Study Dosages

Chickpeas are consumed primarily as a whole food rather than as a standardized dietary supplement. The following dosages have been reported in specific studies:

  • In a randomized crossover intervention studying lipid effects, 27 free-living adults followed two dietary periods of chickpea-supplemented and wheat-supplemented diets, each of at least 5 weeks duration.
  • A 12-week chickpea-enriched diet at 104 g (approximately 1 serving per day, cooked) was used in a study of 45 free-living adults examining lipid outcomes.
  • A pulse-based diet study involving two servings daily of beans, chickpeas, peas, or lentils (approximately 150 g/d dry weight) was administered for 2-month periods to participants aged 50 years or older.
  • Four tablespoons (~100 kcal) of traditional, chickpea-based hummus per day provides approximately 2 cups of legumes per week and approximately 25 grams of dietary fiber.
  • A randomized crossover study used bread containing 0%, 30%, or 60% (wt/wt) cellular chickpea powder (CCP), delivering 50 g total starch per serving, in healthy human participants (n = 20).
  • A chickpea diet dose of 200 g/day in healthy adults was used in a study measuring production of butyrate, a short-chain fatty acid.

As a therapeutic or supplemental agent, there is not yet enough reliable information to determine what an appropriate dose of chickpea might be.

7. Safety Considerations and Interactions

Antinutritional Factors

Chickpeas may contain various antinutritional compounds, including protease inhibitors, phytic acid, lectins, oligosaccharides, and some phenolic compounds that may impair the utilization of nutrients. Chickpea seeds also contain tannins, protease inhibitors (such as trypsin and amylase inhibitors), phytic acid, and saponins that function as anti-nutrients by inhibiting the bioavailability of various nutrient components.

Some polyphenolic compounds, which are present in higher levels in dark-coated chickpeas, bind minerals and reduce their gastrointestinal absorption, causing deficiencies such as anemia; however, these effects are not always consistent and can depend on the individual's personal factors or different processing methods. Saponins display inhibitory digestive enzyme activity, causing issues with digestive health and reduced nutrient absorption and utilization.

Application of different processing techniques—soaking, dehulling, roasting, and germination—improves the nutritional profile of chickpeas along with significant reduction in anti-nutritional factors like tannin, phytic acid, and protease inhibitors.

Gastrointestinal Tolerance

Cooked chickpeas contain complex sugars, fermentable oligosaccharides, disaccharides, monosaccharides, and polyols, which can be difficult to digest and are not completely absorbed by the intestines; these sugars are fermented by bacteria in the large intestine and cause intestinal bloating or trapped gas that causes discomfort.

Allergy

High consumption rates of chickpeas have enhanced allergic problems in sensitive individuals, as they contain many allergens. The proteins in raw chickpeas associated with allergic reaction—such as globulin, albumin, and prolamin—are retained even after the chickpeas are cooked. Histamine released in response to a chickpea allergy gives allergy symptoms like itchy skin, hives, or difficulty breathing; some people experience life-threatening allergic reactions to foods, although a life-threatening reaction to chickpeas is rare.

While chickpea allergy prevalence is lower than peanut/soy, IgE-mediated cross-reactivity with other legumes has been documented. Chickpea might cause allergic reactions in people who are sensitive to latex or to other legumes, such as lentils.

Renal Considerations

Beans are on the list of high phosphorus and high potassium foods, though individual phosphorus and potassium levels will help determine how much can be safely consumed daily. Garbanzo beans are not as high in phosphorus and potassium as other beans and are considered to be of moderate phosphorus and potassium content; research shows that only about 50% of the phosphorus in beans is actually absorbed.

Processing and Safety of Raw Chickpeas

Raw chickpeas contain toxic substances that do not get digested well. Standard cooking (boiling) is essential to deactivate lectins, trypsin inhibitors, and other heat-sensitive antinutritional factors. The chymotrypsin inhibitor content in raw chickpea germplasms is substantially reduced during soaking; roasting (47.25–56.02%) is the most efficient processing method due to the heat-sensitive nature of chymotrypsin inhibitors.

References

Health Conditions

Health conditions that Garbanzo bean may help support.

  • AnemiaScientific

    Garbanzo beans provide approximately 4.7 mg of non-heme iron per cup cooked (~26% of the daily value), making them a meaningful plant-based iron source relevant to iron-deficiency anemia prevention. They also contain vitamin C, which enhances non-heme iron absorption, and folate, which is required for red blood cell maturation.

  • Garbanzo beans are a documented source of antioxidant compounds including polyphenols (quercetin, chlorogenic acid, kaempferol, formononetin, biochanin A, daidzein), selenium, and beta-carotene. These compounds scavenge free radicals, reduce oxidative stress markers, and upregulate antioxidant enzymes. A 2025 in vitro study (Antioxidants journal, PMC12291799) quantified antioxidant activity of chickpea digests and confirmed upregulation of IL-10 and reduction of LPS-induced inflammatory/oxidative stress.

  • The high fiber and protein content of garbanzo beans—approximately 12–15 g fiber and 14–15 g protein per cup cooked—promotes satiety via slowed gastric emptying, stimulation of cholecystokinin (CCK) release, and reduction in postprandial insulin spikes. A meta-analysis of 21 trials (American Journal of Clinical Nutrition, 2016) found that adding pulses including chickpeas to the diet led to modest weight loss even without intentional calorie restriction, consistent with improved satiety.

  • Blood PressureScientific

    Garbanzo beans contain potassium and magnesium—two minerals with established roles in blood pressure regulation—and their bioactive peptides produced by protease hydrolysis inhibit angiotensin-converting enzyme (ACE). Animal studies with chickpea protein hydrolysates show acute hypotensive effects of up to −47 mmHg. Epidemiologic pulse meta-analyses consistently list blood pressure as a benefited cardiometabolic risk factor.

  • Multiple controlled trials and a 2025 systematic review and meta-analysis (28 studies, 40 comparisons) confirm that chickpea consumption significantly reduces postprandial glucose incremental AUC versus carbohydrate-matched controls (MD: −47.89, 95% CI: −64.20 to −31.58, p<0.0001). No significant effect on peak glucose or insulin AUC was observed. Evidence certainty is rated low to very low by GRADE.

  • CholesterolScientific

    Human clinical and epidemiological evidence consistently links chickpea consumption to reductions in total cholesterol and LDL cholesterol. A meta-analysis of 26 randomized controlled trials found that eating one daily serving of pulses including chickpeas lowered LDL by approximately 5%, translating to an estimated 5–6% reduction in cardiovascular disease risk. A 12-week ad libitum dietary trial in 45 adults showed serum total cholesterol and LDL cholesterol fell by approximately 7.7 mg/dL and 7.3 mg/dL respectively.

  • Garbanzo beans contain a range of anti-inflammatory bioactives including polyphenols (quercetin, kaempferol, formononetin, biochanin A), selenium, and fiber-derived SCFAs. Cell model studies (2025, Caco-2 and THP-1) show chickpea digests reduce IL-1β expression and upregulate IL-10. Epidemiologic data link regular chickpea consumption to lower low-grade systemic inflammation, a key driver of chronic disease.

  • ConstipationScientific

    Garbanzo beans contain both soluble and insoluble dietary fiber, which add bulk to stool, accelerate intestinal transit, and promote bowel regularity. A review published in Heliyon (2024, PMC11532829) documented that chickpea dietary fiber prevents constipation and acts as a prebiotic, supporting colonic function.

  • Garbanzo beans are rich in fermentable fiber, resistant starch, and raffinose-family oligosaccharides that serve as prebiotic substrates for beneficial colonic bacteria. These substrates are metabolized to short-chain fatty acids (SCFAs), which modulate gut microbiome composition, support colonocyte function, and enhance gut barrier integrity. Both preclinical and cell-model studies support these effects.

  • Healthy WeightScientific

    Epidemiologic and interventional evidence links chickpea and pulse consumption to modest reductions in body weight and waist circumference. A meta-analysis in the American Journal of Clinical Nutrition (21 trials) found daily pulse consumption associated with weight loss even without intentional caloric restriction. Observational studies report that chickpea consumers have lower body weight, smaller waist circumference, and reduced obesity prevalence.

  • Heart HealthScientific

    Chickpeas support heart health through multiple simultaneous pathways: LDL reduction, triglyceride lowering, blood pressure moderation via potassium and magnesium, and anti-inflammatory polyphenol activity. Epidemiologic and interventional studies link regular pulse consumption, including chickpeas, to reduced cardiovascular disease risk. A 2024 review of 30 clinical and observational studies reported consistent evidence that pulse consumption supports positive cardiovascular outcomes.

  • HomocysteineScientific

    Garbanzo beans are a rich source of folate (vitamin B9), which is the primary dietary regulator of homocysteine metabolism. Adequate folate intake drives the remethylation of homocysteine to methionine via methionine synthase, lowering circulating homocysteine levels, a known independent risk factor for cardiovascular disease. Clinical nutrition literature consistently lists chickpea folate content as cardioprotective via this mechanism.

  • IBSScientific

    The relationship between garbanzo beans and IBS is bidirectional: chickpea fiber can ease constipation-predominant IBS symptoms and reduce gut inflammation, but their high FODMAP content (fermentable oligosaccharides, particularly galacto-oligosaccharides) can trigger bloating, gas, and pain in sensitive IBS individuals. A 2024 Heliyon review (PMC11532829) documented chickpea fiber as reducing IBS symptoms via anti-inflammatory mechanisms.

  • Clinical and preclinical studies demonstrate that chickpea consumption and chickpea bioactive compounds (resistant starch, soluble fiber, isoflavones including biochanin A) can improve insulin sensitivity by slowing glucose absorption, stimulating incretin release, and modulating gut-hormone signaling. A review in Nutrients (PMC5946219) summarized clinical evidence that legumes including chickpeas reduce insulin resistance parameters.

  • Garbanzo beans simultaneously address multiple components of metabolic syndrome—elevated blood glucose, dyslipidemia (high triglycerides, low HDL, high LDL), blood pressure, and abdominal obesity—through their fiber, protein, phytosterol, and bioactive peptide content. Meta-analyses of dietary pulses (Sievenpiper et al. series, ClinicalTrials NCT01594567) include metabolic syndrome as a primary studied condition with favorable outcomes across cardiometabolic risk factors.

  • Prenatal HealthScientific

    Garbanzo beans are one of the richest plant-food sources of folate (vitamin B9), the key nutrient for preventing neural tube defects in the developing fetus, as well as iron (≈4.7 mg/cup cooked, ~26% DV) essential for maternal erythropoiesis and fetal development. Half a cup of chickpea flour provides approximately 50% of the daily folate value.

  • TriglyceridesScientific

    Both human and animal evidence indicate chickpea consumption reduces serum triglycerides. The soluble fiber and polyunsaturated fatty acid content are the primary mediators. UConn Extension, citing clinical data, notes chickpeas help control triglyceride levels, and lipid-lowering effects have been documented across multiple pulse meta-analyses.

Body Systems

Body systems that Garbanzo bean may help support.

  • No body systems available.
Join our newsletter

Stay informed. Stay healthy.

Get expert supplement tips, exclusive discounts, and product recommendations delivered to your inbox

Garbanzo bean | Vitabase